相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Real-world effectiveness and safety profile of teriflunomide in the management of multiple sclerosis in the Gulf Cooperation Council countries: An expert consensus narrative review
Raed Alroughani et al.
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2022)
An updated review of teriflunomide's use in multiple sclerosis
Aaron E. Miller
NEURODEGENERATIVE DISEASE MANAGEMENT (2021)
Fatigue in teriflunomide-treated patients with relapsing remitting multiple sclerosis in the real-world Teri-FAST study
Jerome de Seze et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study
Sebastiano Bucello et al.
JOURNAL OF NEUROLOGY (2021)
Contributing factors to health-related quality of life in multiple sclerosis
Tamas Biernacki et al.
BRAIN AND BEHAVIOR (2019)
Real-life outcomes of teriflunomide treatment in patients with relapsing multiple sclerosis: TAURUS-MS observational study
Boris A. Kallmann et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study
M. Filser et al.
JOURNAL OF NEUROLOGY (2018)
Should I stay or should I go? A prospective investigation examining individual factors impacting employment status among individuals with multiple sclerosis (MS)
Lauren B. Strober et al.
WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION (2018)
Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study
Patricia K. Coyle et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
How Do Pain, Fatigue, Depressive, and Cognitive Symptoms Relate to Well-Being and Social and Physical Functioning in the Daily Lives of Individuals With Multiple Sclerosis?
Anna L. Kratz et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2017)
Teriflunomide in multiple sclerosis: an update
Aaron E. Miller
NEURODEGENERATIVE DISEASE MANAGEMENT (2017)
Brain health: time matters in multiple sclerosis
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Minimal clinically important difference on the Beck Depression Inventory - II according to the patient's perspective
K. S. Button et al.
PSYCHOLOGICAL MEDICINE (2015)
The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life
Daniel Sandi et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study
Aaron E. Miller et al.
JOURNAL OF NEUROLOGY (2014)
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
Christian Confavreux et al.
LANCET NEUROLOGY (2014)
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial
Patrick Vermersch et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis
Jeremy Hobart et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
D. W. Langdon et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study
F. Patti et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
Paul O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Validation of the Fatigue Impact Scale in Hungarian patients with multiple sclerosis
Erika Losonczi et al.
QUALITY OF LIFE RESEARCH (2011)
A novel approach to estimate the minimally important difference for the fatigue impact scale in multiple sclerosis patients
Regina Rendas-Baum et al.
QUALITY OF LIFE RESEARCH (2010)
Cross-cultural adaptation and validation of the 'Multiple Sclerosis Quality of Life Instrument' in Hungarian
J. Fuevesi et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses
PW O'Connor et al.
NEUROLOGY (2006)
Drug therapy - Adherence to medication
L Osterberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change
RHB Benedict et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing
AJ Mitchell et al.
LANCET NEUROLOGY (2005)
Validation of the Health-Related Productivity Questionnaire Diary (HRPQ-D) on a sample of patients with infectious mononucleosis: Results from a phase 1 multicenter clinical trial
RN Kumar et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2003)
分享论文
